Grand Rounds

Grand Rounds lectures are a tradition and integral component of medical education. Given by experts, these lectures are research presentations that focus on current or interesting cases. They are also often utilized for dissemination of new research information.

The OSUCCC – James Grand Rounds schedule follows The Ohio State University’s academic calendar. The lectures take place on Friday mornings at 8 a.m. in The James, Room L035  (Wasserstrom Family Conference Room on the conference level), but they are not held on the second Friday of the month, during the summer academic break, or during most weeks that contain a university-sanctioned holiday.

2018-2019 Grand Rounds Speakers





September 7, 2018 Hassane Zarour, MD University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center
September 21, 2018 Clara Lee, MD,  Department of Plastic Surgery; Tatiana Oberyszyn, PhD, Department of Pathology; Fuhai Li, PhD, Department of Biomedical Informatics The Ohio State University Pelotonia Idea Grant Presentations
October 5, 2018 Charles von Gunten, MD Ohio Health
October 26, 2018 Frank Furnari, PhD University of California at San Diego, The Ludwig Institute for Cancer Research
November 2, 2018 Aharon “Ronnie” Freud, MD, PhD The Ohio State University
EBV+ Extranodal NK/T Cell Lymphoma Shows Features of Tissue-Resident NK Cell Precursors
Gina Sizemore, PhD The Ohio State University
Using Novel Mouse Models to Explore the Breast Cancer-Associated Brain Metastatic Microenvironment
November 16, 2018 Sophia Wang, PhD City of Hope National Medical Center
Human Leukocyte Antigen (HLA) Alleles, Haplotypes, and Diversity in Non-Hodgkin Lymphoma Etiology and Survival
November 30, 2018 Philip W. Hinds, PhD Tufts University School of Medicine
Ax or Scalpel – How Best to Target AKT in BRAFV600E-Dependent Melanoma?
December 7, 2018 Richard Fishel, PhD The Ohio State University
Visualizing DNA Mismatch Repair in Real Time Reveals the Completely Stochastic Nature of Biological Processes
January 18, 2019 Erwin G. Van Meir, PhD Emory University

January 25, 2019 Michael Knopp, MD The Ohio State University

February 1, 2019 Amy LeBlanc, DVM National Cancer Institute (NCI) The Comparative Approach to Cancer Drug Development: Integration of Canine Models
February 15, 2019 Jennifer Woyach, MD The Ohio State University
Evolving Frontline Therapy for Chronic Lymphocytic Leukemia
February 22, 2019 Douglas Yee, MD University of Minnesota Department of Medicine What We Learned by Treating Breast Cancer With Insulin-Like Growth Factor Receptor Inhibitors
March 1, 2019 Stephen Baylin, MD Johns Hopkins University DNA Methylation Abnormalities – Helping to Initiate Cancer and Presenting a Potential Therapy Target
March 15, 2019 Timothy Pawlik, MD, MPH, PhD The Ohio State University Intrahepatic Cholangiocarcinoma: Clinical Approaches to a Challenging Tumor
April 5, 2019 Zihai Li, MD, PhD The Ohio State University Immunotherapy, Platelets and GARP, Oh My
April 19, 2019 Lawrence Kirschner, MD, PhD The Ohio State University Of Mice and MEN: Using Mouse Models to Understand Endocrine Tumor Genetics
May 3, 2019 John Coffin, PhD Tufts University
May 17, 2019 Lei Zheng, MD, PhD Johns Hopkins University Overcoming the Therapeutic Challenges in Pancreatic Cancer in the Era of Precision Medicine and Immuno-Oncology: It Takes an Army

If you missed a Grand Round lecture, you can view the live stream or the on demand recording after each lecture. You will need to sign in and register the first time you view it.

If you would like to receive our weekly Grand Rounds email update, please send your name and email address to

If you have any general questions about Grand Rounds, you can contact Tamra Brooks.

The Ohio State University Wexner Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians. The Ohio State University Wexner Medical Center, Center for Continuing Medical Education designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Evolving Frontline Therapy for Chronic Lymphocytic Leukemiaevolving

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Find a Scientific Publication